🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

During #mito disease awareness week the whole MitoCAMB team has come together to share knowledge, experience & ideas at our away day. Lots of fun, but also a chance to build relationships & facilitate even better research for the future! Jelle van den Ameele Horvath Lab MRC MBU Nell Yu Nie

The UCL portico has been green for mito all this week to raise awareness for this under-diagnosed group of diseases #worldmitoweek2024 #lightupformito The Lily Foundation

Great presentations from our team at NMSG 2024- very proud of such a talented hard working team focussed on improving the lives of NMD patients Neuromuscular Study Group UCLH UCL Brain Sciences UCL_QS_CNMD Muscular Dystrophy UK

We are excited to have been awarded funding to expand our technological abilities to visualise molecules maintaining spatial information. Spatial metabolomics is going to be a game changer. Read our story here! nmgn.mrc.ukri.org/news/the-netwo…

We are proud media partners (with Mary Lyon Centre at MRC Harwell) for Cambridge Rare Disease Network (CamRARE) #RAREfest24 on 23 Nov, making #RareDiseases an everyday conversation. Get FREE tickets at bit.ly/RAREfest24_Home for this festival for curious minds celebrating science, technology, community, and the arts.

The Haem Team from the Centre for Blood Research Centre for Blood Research and MRC NMGN Haem Cluster took part in the #ShineWalk around York to raise funds for Cancer Research Cancer Research UK. Lots of fun was had and lots of money raised! Any last minute donations gratefully received!👇👇 fundraise.cancerresearchuk.org/team/centre-fo…

And today we are at #ELRIGDD24 to bring our activities and #preclinical expertise to industry partners and the drug discovery community #DD2024

And now Robert Pitceathly of the MRC MitoCluster reporting to #ELRIGDD24 about the network and what we can do to advance #therapeutics for #geneticdiseases making use of our #mousemodels at Mary Lyon Centre at MRC Harwell

Apply by 20 Oct! We are hiring a Research Assistant in #Bioinformatics to work on mitochondrial disease research and diagnostics. This is an opportunity to make a meaningful impact on patients' lives while contributing to cutting-edge research. ucl.ac.uk/work-at-ucl/se…

We've made a new video showing how we work with mice at the Mary Lyon Centre for #AnimalsInResearch week (Understanding Animal Research), highlighting our commitment to the 3Rs and the improvement or development of sophisticated tests to better understand disease: youtube.com/watch?v=izV5nV…

Next edition of IMol Science Club with Prof. Michal Minczuk on October 16, 2024 at 2 pm! Prof. Minczuk will give a lecture on "The potential of mitochondrial genome engineering”.

We’re #hiring a Molecular Biologist and Senior Molecular Biologist to work as part of a mouse genome-editing pipeline and on collaborative development of Genome Engineering technologies. DEADLINE - 13th October Please RT or apply today! mrc.tal.net/vx/lang-en-GB/…

An excellent talk from Jelle van den Ameele if we do say so ourselves!

Planned workshops include one led by our Director, Sara Wells, and one led by the MRC MitoCluster:

A key part of our mission is to train #ECRs to carry out their in vivo work in the most scientifically rigorous way. With that in mind, we recently held a week-long bootcamp at Mary Lyon Centre at MRC Harwell focused on the use of mouse models to study human disease: nmgn.mrc.ukri.org/news/our-missi…

🚨 Exciting news for mitochondrial disease research! Abliva's KL1333 Phase 1a/b study, published in Brain, showed the drug is safe and demonstrates early signs of efficacy. A milestone for rare disease therapeutics! Read more: academic.oup.com/brain/article-…

Thanks to UCL Queen Square Institute of Neurology UCL Research for highlighting our paper: KL1333 trial results in mitochondrial diseases ucl.ac.uk/brain-sciences…

An early clinical trial, led by researchers at UCL Queen Square Institute of Neurology, shows promising results for adults with primary mitochondrial disease, with reduced fatigue and improved functional strength. Chiara Pizzamiglio Robert Pitceathly bit.ly/4ge2Igd

Collaborative paper published with Carlos Moraes' group and MitoCluster's James Stewart! Using mitochondrial DdCBE base editors to correct a pathogenic mutation in our heteroplasmic m.5024C>T mice. 🧪 science.org/doi/10.1126/sc… #mtdna #geneticengineering #mito MRC National Mouse Genetics Network